Survival Associations of Timely Postoperative Radiotherapy Among Head and Neck Cancer High-Risk Subgroups

被引:0
|
作者
Velez, Lisa M. Velez [1 ]
Corpuz, Timothy V. [1 ]
Schwetschenau, Luke C. [1 ]
Mazul, Angela [2 ]
Massa, Sean T. [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63103 USA
[2] Washington Univ, Sch Med St Louis, Dept Otolaryngol Head & Neck Surg, St Louis, MO USA
关键词
head and neck cancer; postoperative radiotherapy; survival; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; TREATMENT DELAYS; SURGERY; DISPARITIES; INITIATION; IMPACT; RACE;
D O I
10.1002/lary.32074
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ObjectiveEffective implementation of timely postoperative radiation therapy (PORT) as a quality metric for head and neck squamous cell carcinoma (HNSCC) care may reduce survival disparities in subgroups with the highest risk of mortality-advanced stage and Black race. We sought to determine if the association between timely PORT and survival varies among clinical and demographic high-risk subgroups.MethodsIn this retrospective cohort study using the National Cancer Database 2004-2020, patients with HPV-negative HNSCC treated with surgery and PORT were identified. The association between PORT delay greater than 6 weeks with overall survival was assessed by Cox proportional hazards models with interaction effects for race, overall stage, and PORT delay.ResultsAmong 54,035 patients included in the study, 62% (33491) had PORT delays. Black patients were more likely to have PORT delays (aOR 1.19, 95% CI: 1.10-1.27). Timely PORT was only associated with improved survival for all stage I patients and White stage IV patients (predicted mortality risk 2.53, 95% CI: 2.34-2.74 versus 2.88, 95% CI: 2.67-3.09, referenced to White, stage I). After adjusting for covariates, timely PORT was estimated to be associated with inferior overall survival in Black patients with stage IV disease although with low precision (predicted mortality risk 3.24, 95% CI: 2.87-3.66, versus 2.71, 95% CI: 2.47-2.98, referenced to White, stage I).ConclusionTimely, guideline-adherent PORT may not reduce survival disparities in Black patients, especially those with advanced stage disease, suggesting other interventions are needed to address this disparity.Level of Evidence3.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival
    Casas, F.
    Valduvieco, I.
    Oses, G.
    Izquierdo, L.
    Archila, I.
    Costa, M.
    Cortes, K. S.
    Barreto, T.
    Ferrer, F.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03) : 355 - 362
  • [42] Assessment of adjuvant therapy in resected head and neck cancer with high-risk features
    Ajmani, Gaurav S.
    Nocon, Cheryl C.
    Wang, Chi-Hsiung
    Bhayani, Mihir K.
    ORAL ONCOLOGY, 2017, 74 : 15 - 20
  • [43] Phase I Adjuvant Radiation With Docetaxel in High-Risk Head and Neck Cancer
    Clark, Joseph I.
    Eisner, Robert M.
    Hofmeister, Craig
    Norton, John
    Thomas, Sachdev
    Choudhury, Abdul
    Petruzzelli, Guy
    Lathers, Deanne
    Young, M. Rita I.
    Lau, Ann
    Emami, Bahman
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (04): : 396 - 400
  • [44] IMMUNOSUPPRESSION FOLLOWING POSTOPERATIVE RADIOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER
    MAIER, H
    DANIEL, V
    HEIMLICH, F
    FRANK, C
    OPELZ, G
    HNO, 1995, 43 (06) : 364 - 370
  • [45] Postoperative Chemoradiation in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Bhatia, Aarti K.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (13) : 1269 - +
  • [46] Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma
    Porceddu, SV
    Campbell, B
    Rischin, D
    Corry, J
    Weih, L
    Guerrieri, M
    Grossi, M
    Peters, LJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 365 - 373
  • [47] Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy
    Li, Yan
    Awan, Musaddiq J.
    Chang, Tangel
    Lavertu, Pierre
    Zender, Chad
    Rezaee, Rod
    Fowler, Nicole
    Wasman, Jay
    Avril, Norbert E.
    Chen, Nianyong
    Machtay, Mitchell
    Yao, Min
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (04) : 794 - 800
  • [48] Long-Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High-Risk Head and Neck Cancer
    Argiris, Athanassios
    Karamouzis, Michalis V.
    Johnson, Jonas T.
    Heron, Dwight E.
    Myers, Eugene
    Eibling, David
    Cano, Elmer
    Urba, Susan
    Gluckman, Jack
    Grandis, Jennifer R.
    Wang, Yun
    Agarwala, Sanjiv S.
    LARYNGOSCOPE, 2008, 118 (03) : 444 - 449
  • [49] Postoperative radiotherapy of intermediate-risk head and neck cancer in 134 patients: Does subset matter?
    Ampil, Federico L.
    Caldito, Gloria
    Nathan, Cherie-Ann
    Vora, Moiz
    Richards, Troy
    CLINICAL OTOLARYNGOLOGY, 2019, 44 (02) : 176 - 178
  • [50] PET-based prognostic survival model after radiotherapy for head and neck cancer
    Castelli, Joel
    Depeursinge, A.
    Devillers, A.
    Campillo-Gimenez, B.
    Dicente, Y.
    Prior, J. O.
    Chajon, E.
    Jegoux, F.
    Sire, C.
    Acosta, O.
    Gherga, E.
    Sun, X.
    De Bari, B.
    Bourhis, J.
    de Crevoisier, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 638 - 649